G
G. Wilson
Researcher at Manchester Royal Infirmary
Publications - 14
Citations - 1508
G. Wilson is an academic researcher from Manchester Royal Infirmary. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 9, co-authored 13 publications receiving 1150 citations.
Papers
More filters
Journal ArticleDOI
Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial
Stephanie M. de Boer,Melanie E Powell,Linda Mileshkin,Dionyssios Katsaros,Paul Bessette,Christine Haie-Meder,Petronella B. Ottevanger,Jonathan A. Ledermann,Pearly Khaw,Alessandro Colombo,Anthony Fyles,Marie Helene Baron,Ina M. Jürgenliemk-Schulz,Henry C Kitchener,Hans W. Nijman,G. Wilson,Susan Brooks,Silvestro Carinelli,Diane Provencher,Chantal Hanzen,Ludy C.H.W. Lutgens,Vincent T.H.B.M. Smit,Naveena Singh,V. Do,Romerai D'Amico,Remi A. Nout,Amanda Feeney,Karen W Verhoeven-Adema,Hein Putter,Carien L. Creutzberg,Mary McCormack,Karen Whitmarsh,Rozenn Allerton,Deborah Gregory,P. Symonds,Peter Hoskin,Madhavi Adusumalli,Anjana Anand,Robert Wade,Alexandra J. Stewart,Wendy Taylor,Roy F.P.M. Kruitwagen,Harry Hollema,Elizabeth Pras,An Snyers,Lukas J.A. Stalpers,Jan J. Jobsen,Annerie Slot,Jan Willem M. Mens,Tanja C. Stam,Baukelien Van Triest,Elzbieta M. Van der Steen Banasik,Karin A.J. De Winter,Michael A. Quinn,Ilka Kolodziej,Jan Pyman,Carol Johnson,Anne Capp,Roldano Fossati,Sergio Gribaudo,Andrea Lissoni,Annamaria Ferrero,Grazia Artioli,Cathy Davidson,C. Meg McLachlin,Prafull Ghatage,Paula V.C. Rittenberg,Luis Souhami,Gillian Thomas,Pierre Duvillard,Dominique Berton-Rigaud,Nicole Tubiana-Mathieu +71 more
TL;DR: Adjuvant chemotherapy given during and after radiotherapy for high-risk endometrial cancer did not improve 5-year overall survival, although it did increase failure-free survival.
Journal ArticleDOI
Incidence of cerebral metastases in patients treated with trastuzumab for metastatic breast cancer
A. Clayton,Sarah Danson,S Jolly,W.D.J. Ryder,Paul A Burt,Aengus Stewart,Peter M Wilkinson,R S Welch,B. Magee,G. Wilson,Anthony Howell,Andrew M Wardley +11 more
TL;DR: A high proportion of patients with MBC treated with trastuzumab develop symptomatic cerebral metastases, which indicates that HER-2-positive breast cancer may have a predilection for the brain, or trastzumab therapy may change the disease pattern by prolonging survival.
Journal ArticleDOI
Worldwide human papillomavirus genotype attribution in over 2000 cases of intraepithelial and invasive lesions of the vulva
Silvia de Sanjosé,Laia Alemany,Jaume Ordi,Sara Tous,Maria Alejo,Susan M. Bigby,Elmar A. Joura,Paula Maldonado,Jan Laco,Ignacio G. Bravo,August Vidal,Núria Guimerà,Paul Cross,Gerard Wain,Karl Ulrich Petry,Luciano Mariani,Christine Bergeron,Václav Mandys,Adela Rosa Sica,Ana Félix,Alp Usubutun,Muhieddine Seoud,Gustavo Hernández-Suárez,Andrzej Nowakowski,G. Wilson,Véronique Dalstein,Monika Hampl,Elena Kasamatsu,Luis Estuardo Lombardi,Leopoldo Tinoco,Isabel Alvarado-Cabrero,Myriam Perrotta,Neerja Bhatla,Theodoros Agorastos,Charles F. Lynch,Marc T. Goodman,Hai Rim Shin,Halina Viarheichyk,Robert Jach,M. O.L.Eugenia Cruz,Julio Velasco,Carla Molina,Jacob Bornstein,Annabelle Ferrera,Efren J. Domingo,Cheng Yang Chou,Adekunbiola Aina Fehintola Banjo,Xavier Castellsagué,Michael Pawlita,Belen Lloveras,Wim Quint,Nubia Muñoz,F. Xavier Bosch +52 more
TL;DR: Combined data from HPV-DNA and p16(INK4a) testing are likely to represent a closer estimate of the real fraction of IVC induced by HPV, indicating that HPV contribution in invasive vulvar cancer has probably been overestimated.
Journal ArticleDOI
Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial
Stephanie M. de Boer,Melanie E Powell,Linda Mileshkin,Dionyssios Katsaros,Paul Bessette,Christine Haie-Meder,Petronella B. Ottevanger,Jonathan A. Ledermann,Pearly Khaw,Romerai D'Amico,Anthony Fyles,Marie-Helene Baron,Ina M. Jürgenliemk-Schulz,Henry C Kitchener,Hans W. Nijman,G. Wilson,Susan Brooks,Sergio Gribaudo,Diane Provencher,Chantal Hanzen,Roy F.P.M. Kruitwagen,Vincent T.H.B.M. Smit,Naveena Singh,V. Do,Andrea Lissoni,Remi A. Nout,Amanda Feeney,Karen W Verhoeven-Adema,Hein Putter,Carien L. Creutzberg,M McCormack,K Whitmarsh,R Allerton,Deborah Gregory,P. Symonds,Peter Hoskin,M Adusumalli,Anjana Anand,R Wade,Alexandra J. Stewart,W Taylor,L.C.H.W. Lutgens,Harmen Hollema,Elisabeth Pras,An Snyers,GH Westerveld,J.J. Jobsen,Annerie Slot,J.W.M. Mens,Tanja C. Stam,B. van Triest,E. Van der Steen-Banasik,Kaj De Winter,Michael A. Quinn,Ilka Kolodziej,Jan Pyman,Colin D. Johnson,Anne Capp,Roldano Fossati,Alessandro Colombo,Silvestro Carinelli,Annamaria Ferrero,G Artioli,C Davidson,C M McLachlin,Prafull Ghatage,Pvc Rittenberg,Luis Souhami,Gillian Thomas,Pierre Duvillard,Dominique Berton-Rigaud,Nicole Tubiana-Mathieu +71 more
TL;DR: The PORTEC-3 trial investigated the benefit of combined adjuvant chemotherapy and radiotherapy versus pelvic radiotherapy alone for women with high-risk endometrial cancer and did a post-hoc survival analysis to investigate patterns of recurrence.
Journal ArticleDOI
Clinical consequences of upfront pathology review in the randomised PORTEC-3 trial for high-risk endometrial cancer.
S. M. de Boer,Bastiaan G Wortman,Tjalling Bosse,Melanie E Powell,Naveena Singh,Harry Hollema,G. Wilson,M N Chowdhury,Linda Mileshkin,Jan Pyman,Dionyssios Katsaros,Silvestro Carinelli,Anthony Fyles,C M McLachlin,Christine Haie-Meder,Pierre Duvillard,Remi A. Nout,Karen W Verhoeven-Adema,Hein Putter,Carien L. Creutzberg,Vthbm Smit +20 more
TL;DR: Central pathology review by expert gynaeco-pathologists changed histological type, grade or other items in 43% of women with high-risk endometrial cancer, leading to ineligibility for the PORTEC-3 trial in 8%.